We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$85.3M
Cap. Flow
-$23.1M
Cap. Flow %
-3.19%
Top 10 Hldgs %
36.06%
Holding
97
New
24
Increased
24
Reduced
14
Closed
32

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$23M
2
DXCM icon
DexCom
DXCM
+$19.7M
3
MDT icon
Medtronic
MDT
+$18.4M
4
BDX icon
Becton Dickinson
BDX
+$17.6M
5
AMGN icon
Amgen
AMGN
+$16.2M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$34.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$29.2M
3
COO icon
Cooper Companies
COO
+$13.6M
4
CNC icon
Centene
CNC
+$13.5M
5
ABBV icon
AbbVie
ABBV
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.17%
2 Consumer Discretionary 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
76
DELISTED
Exact Sciences
EXAS
– –
-88,000
Closed -$8.26M
FOLD
77
DELISTED
Amicus Therapeutics
FOLD
– –
-387,000
Closed -$4.86M
GSK icon
78
GSK
GSK
$101B
– –
-350,000
Closed -$12.5M
ISRG icon
79
Intuitive Surgical
ISRG
$142B
– –
-36,000
Closed -$12.3M
JNJ icon
80
Johnson & Johnson
JNJ
$629B
– –
-72,000
Closed -$11.9M
KROS icon
81
Keros Therapeutics
KROS
$212M
– –
-52,000
Closed -$2.09M
NTLA icon
82
Intellia Therapeutics
NTLA
$1.7B
– –
-206,000
Closed -$8.4M
NVO
83
PUT
Novo Nordisk
NVO
$203B
– –
-500,000
Closed -$40.5M
PEN icon
84
Penumbra
PEN
$12.9B
– –
-30,000
Closed -$10.3M
PRTA icon
85
Prothena Corp
PRTA
$474M
– –
-52,000
Closed -$3.55M
PRVA icon
86
Privia Health
PRVA
$2.75B
– –
-200,000
Closed -$5.22M
PTCT icon
87
PTC Therapeutics
PTCT
$6.14B
– –
-174,000
Closed -$7.08M
PTGX icon
88
Protagonist Therapeutics
PTGX
$9.86B
– –
-75,000
Closed -$2.07M
QURE icon
89
CALL
uniQure
QURE
$3.14B
– –
-200,000
Closed -$2.29M
SAGE
90
DELISTED
Sage Therapeutics
SAGE
– –
-80,000
Closed -$3.76M
SDGR icon
91
Schrodinger
SDGR
$1.39B
– –
-265,000
Closed -$13.2M
SGRY icon
92
Surgery Partners
SGRY
$2B
– –
-250,000
Closed -$11.2M
TERN
93
DELISTED
Terns Pharmaceuticals
TERN
– –
-180,000
Closed -$1.57M
TGTX icon
94
TG Therapeutics
TGTX
$7.65B
– –
-250,000
Closed -$6.21M
WBA
95
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-100,000
Closed -$2.85M
XRAY icon
96
Dentsply Sirona
XRAY
$2.25B
– –
-100,000
Closed -$4M
RETA
97
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-120,000
Closed -$12.2M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Integral Health Asset Management held 97 positions worth $722M, down 11% from $808M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $23.1M in Q3 2023, closing 32 positions and reducing 14 holdings. Its most notable exit was Centene, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Integral Health Asset Management opened a new position in DexCom worth $16.3M.

  • Integral Health Asset Management's largest Q3 2023 buy was DexCom: 175,000 shares worth $16.3M.
  • Integral Health Asset Management added most to Tenet Healthcare in Q3 2023, an estimated $23M increase.
  • Integral Health Asset Management's biggest Q3 2023 reduction was Cigna, cutting an estimated $34.2M.
  • Integral Health Asset Management fully exited Centene in Q3 2023, selling an estimated $13.5M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $722M portfolio in Q3 2023.
  • Integral Health Asset Management opened 24 new positions and closed 32 in Q3 2023.
  • Integral Health Asset Management's portfolio value fell 11% quarter-over-quarter to $722M.

Based on Integral Health Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.